Legal News

Guidance for exportation of active substances manufactured in Great Britain

Published on: 03 March 2021
Published by LNB News

LNB News 03/03/2021

Document Information

Issue Date: 03 March 2021

Published Date: 03 March 2021

Jurisdiction(s): England, Northern Ireland, Scotland, Wales and European Union

Article summary

The Medicines and Healthcare products Regulatory Agency has updated guidance on exporting active substances for human use manufactured in Great Britain for use in the EEA and Northern Ireland relating to the written confirmations for export required for third country export to the EEA under Article 46b(2)(b) of Directive 2001/83/EC​.

Popular documents